4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-027547
President and CEO sold 18,334 shares at an average $24.20 ($443,744)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2019-05-01 | Sale | −6,112 | $24.09 | $147,238 | 2,591,526 | I: show line 1 in the form |
| Watts Ryan J. President and CEO | 2019-05-02 | Sale | −6,111 | $24.03 | $146,847 | 2,585,415 | I: show line 2 in the form |
| Watts Ryan J. President and CEO | 2019-05-03 | Sale | −6,111 | $24.49 | $149,658 | 2,579,304 | I: show line 3 in the form |
| Open-market sales · 18,334 sh · avg $24.20 · $443,744 | |||||||
Loading xslF345X03/doc4.xml…